Compare IPCA Labs with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS AJANTA PHARMA IPCA LABS/
AJANTA PHARMA
 
P/E (TTM) x 22.1 25.9 85.4% View Chart
P/BV x 7.0 5.9 119.7% View Chart
Dividend Yield % 0.2 0.5 51.4%  

Financials

 IPCA LABS   AJANTA PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-20
AJANTA PHARMA
Mar-21
IPCA LABS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,6161,883 85.8%   
Low Rs8441,258 67.1%   
Sales per share (Unadj.) Rs363.2314.2 115.6%  
Earnings per share (Unadj.) Rs48.478.1 62.0%  
Cash flow per share (Unadj.) Rs65.091.0 71.5%  
Dividends per share (Unadj.) Rs5.009.50 52.6%  
Dividend yield (eoy) %0.40.6 67.2%  
Book value per share (Unadj.) Rs286.2333.3 85.8%  
Shares outstanding (eoy) m126.3586.53 146.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.45.0 67.7%   
Avg P/E ratio x25.420.1 126.4%  
P/CF ratio (eoy) x18.917.3 109.5%  
Price / Book Value ratio x4.34.7 91.2%  
Dividend payout %10.312.2 84.9%   
Avg Mkt Cap Rs m155,407135,898 114.4%   
No. of employees `000NANA-   
Total wages/salary Rs m9,2124,981 184.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m45,89427,186 168.8%  
Other income Rs m8651,036 83.5%   
Total revenues Rs m46,75928,222 165.7%   
Gross profit Rs m8,9059,169 97.1%  
Depreciation Rs m2,1051,115 188.8%   
Interest Rs m19869 286.5%   
Profit before tax Rs m7,4679,021 82.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,3532,265 59.8%   
Profit after tax Rs m6,1146,756 90.5%  
Gross profit margin %19.433.7 57.5%  
Effective tax rate %18.125.1 72.2%   
Net profit margin %13.324.9 53.6%  
BALANCE SHEET DATA
Current assets Rs m28,55720,264 140.9%   
Current liabilities Rs m13,2647,063 187.8%   
Net working cap to sales %33.348.6 68.6%  
Current ratio x2.22.9 75.0%  
Inventory Days Days3653 66.7%  
Debtors Days Days711 67.8%  
Net fixed assets Rs m24,02118,860 127.4%   
Share capital Rs m253174 145.3%   
"Free" reserves Rs m35,90328,670 125.2%   
Net worth Rs m36,15528,844 125.3%   
Long term debt Rs m1,0300-   
Total assets Rs m52,57839,124 134.4%  
Interest coverage x38.8131.7 29.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.7 125.6%   
Return on assets %12.017.4 68.8%  
Return on equity %16.923.4 72.2%  
Return on capital %20.631.5 65.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m21,43818,097 118.5%   
Fx outflow Rs m9,0222,315 389.8%   
Net fx Rs m12,41515,782 78.7%   
CASH FLOW
From Operations Rs m5,6434,670 120.8%  
From Investments Rs m-5,097-1,627 313.3%  
From Financial Activity Rs m-1,305-2,689 48.5%  
Net Cashflow Rs m-755354 -213.3%  

Share Holding

Indian Promoters % 46.3 70.3 65.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 42.6 21.0 202.8%  
FIIs % 17.5 8.4 208.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 29.7 181.1%  
Shareholders   100,626 44,881 224.2%  
Pledged promoter(s) holding % 0.0 15.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   VENUS REMEDIES  IND SWIFT LA  PANACEA BIOTECH  SYSCHEM (I).  SUVEN PHARMACEUTICALS  

Compare IPCA LABS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Maruti Suzuki and UPL Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity today and ended on a flat note.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

My 'Unlock' Investments(Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth(Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

The Most Visible Sign of India's Revival is on Two Wheels(Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Wednesday's Market Fall Explained(Fast Profits Daily)

Jun 10, 2021

This is why the stock market fell the way it did on Wednesday.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Jun 22, 2021 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IPCA LABS WITH

MARKET STATS